KLK3 and Familial prostate cancer: In the intervention group, plasma prostate-specific antigen (PSA) levels decreased by 18% while in the control group they increased by 14%, and considering all biomarkers the authors concluded that lycopene supplementation may decrease the growth of prostate cancer, though the sample was too small to be conclusive.